We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+12.56%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$283M
AUM Growth
+$21.1M
Cap. Flow
+$9.63M
Cap. Flow %
3.41%
Top 10 Hldgs %
64.36%
Holding
124
New
11
Increased
16
Reduced
11
Closed
18

Top Buys

Rank Stock Value
1
WEST icon
Westrock Coffee
WEST
+$4.78M
2
PFE icon
Pfizer
PFE
+$4.16M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$3.35M
4
IMVT icon
Immunovant
IMVT
+$3.06M
5
DMRC icon
Digimarc Corp
DMRC
+$2.89M

Top Sells

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$9.6M
2
VKTX icon
Viking Therapeutics
VKTX
+$7.54M
3
ARDX icon
Ardelyx
ARDX
+$4.75M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$2.64M
5
CHRS icon
Coherus Oncology
CHRS
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 30.07%
2 Materials 23.48%
3 Financials 12.15%
4 Industrials 6.91%
5 Communication Services 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMRC icon
26
Digimarc Corp
DMRC
$133M
$2.27M 0.8%
+83,557
New +$2.89M
SNY icon
27
Sanofi
SNY
$105B
$2.19M 0.77%
45,000
-2,000
-4% -$97.7K
CVE icon
28
Cenovus Energy
CVE
$53.1B
$1.9M 0.67%
95,000
– –
VRNA
29
DELISTED
Verona Pharma
VRNA
$1.85M 0.65%
115,000
+82,328
+252% +$1.42M
TVTX icon
30
Travere Therapeutics
TVTX
$5.18B
$1.78M 0.63%
230,966
+9,961
+5% +$84K
AB icon
31
AllianceBernstein
AB
$3.54B
$1.7M 0.6%
49,000
– –
SNDX icon
32
Syndax Pharmaceuticals
SNDX
$2B
$1.56M 0.55%
+65,475
New +$1.46M
XBI icon
33
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$1.52M 0.54%
16,000
+13,000
+433% +$1.21M
PTGX icon
34
Protagonist Therapeutics
PTGX
$8.89B
$1.51M 0.54%
52,368
– –
RHP icon
35
Ryman Hospitality Properties
RHP
$8.01B
$1.39M 0.49%
12,000
– –
XERS icon
36
Xeris Biopharma Holdings
XERS
$1.5B
$1.33M 0.47%
600,000
+212,090
+55% +$549K
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$122B
$1.25M 0.44%
3,000
– –
SYRS
38
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.25M 0.44%
233,000
+153,073
+192% +$1.06M
EOLS icon
39
Evolus
EOLS
$360M
$1.12M 0.4%
80,000
+6,934
+9% +$90.1K
EDIT icon
40
Editas Medicine
EDIT
$445M
$1.04M 0.37%
+140,000
New +$1.16M
XENE icon
41
Xenon Pharmaceuticals
XENE
$6.51B
$1.03M 0.36%
23,866
– –
MDLZ icon
42
Mondelez International
MDLZ
$77.4B
$980K 0.35%
14,000
– –
MDGL icon
43
Madrigal Pharmaceuticals
MDGL
$12.4B
$957K 0.34%
3,584
-11,216
-76% -$2.64M
ABBV icon
44
AbbVie
ABBV
$448B
$917K 0.32%
5,037
– –
KMB icon
45
Kimberly-Clark
KMB
$36B
$776K 0.27%
6,000
– –
DD icon
46
DuPont de Nemours
DD
$18.5B
$761K 0.27%
7,911
– –
MSFT icon
47
Microsoft
MSFT
$2.98T
$673K 0.24%
1,600
– –
CTVA icon
48
Corteva
CTVA
$58.4B
$667K 0.24%
11,563
– –
DOW icon
49
Dow Inc
DOW
$21.9B
$645K 0.23%
11,136
– –
CNQ icon
50
Canadian Natural Resources
CNQ
$91.7B
$641K 0.23%
16,800
– –
1
2
3 4 5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
TT
TI-Trust Quincy, Illinois $168M AUM 24.32% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return

David M. Knott Jr's Q1 2024 Portfolio in Review

As of Q1 2024, David M. Knott Jr held 124 positions worth $283M, up 8.1% from $262M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

David M. Knott Jr deployed $9.63M of net new capital in Q1 2024, opening 11 new positions and adding to 16 existing holdings. Its largest new stake was Westrock Coffee: 473,597 shares worth $4.89M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Materials and Financials.

On the sell side, the largest reduction was FTAI Aviation, an estimated $9.6M trimmed.

  • David M. Knott Jr's largest Q1 2024 buy was Westrock Coffee: 473,597 shares worth $4.89M.
  • David M. Knott Jr added most to Pfizer in Q1 2024, an estimated $4.16M increase.
  • David M. Knott Jr's biggest Q1 2024 reduction was FTAI Aviation, cutting an estimated $9.6M.
  • David M. Knott Jr fully exited Abeona Therapeutics in Q1 2024, selling an estimated $993K.
  • David M. Knott Jr's ten largest holdings make up 64% of its $283M portfolio in Q1 2024.
  • David M. Knott Jr opened 11 new positions and closed 18 in Q1 2024.
  • David M. Knott Jr's portfolio value rose 8.1% quarter-over-quarter to $283M.

Based on David M. Knott Jr's 13F filing for Q1 2024, filed 14 May 2024.